Literature DB >> 6724662

Effect of antihypertensive treatment on the behavioral consequences of elevated blood pressure.

R E Miller, A P Shapiro, H E King, E H Ginchereau, J A Hosutt.   

Abstract

It was shown in a prior study that mildly hypertensive patients performed significantly less effectively on several sensory-perceptual, cognitive, and psychomotor tests than did matched normotensive controls. To determine whether these deficits are attributable to elevated blood pressure per se, hypertensive and control subjects were recalled for reexamination 15 months after the original tests. Results indicated that those hypertensives in whom blood pressure had been lowered with antihypertensive drugs showed significant restoration of performance scores toward the levels of normotensive subjects. Hypertensives who had not received active treatment remained deficient as compared with controls. These results indicated that behavioral deficits in mild hypertension may be reversible consequences of the effects of elevated blood pressure on the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724662

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

1.  Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults.

Authors:  Caterina Rosano; Anne B Newman; Ronit Katz; Calvin H Hirsch; Lewis H Kuller
Journal:  J Am Geriatr Soc       Date:  2008-08-05       Impact factor: 5.562

Review 2.  Are cognitive function and blood pressure related?

Authors:  M Viitanen; Z Guo
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

3.  Cognitive function in hypertensives treated with atenolol or propranolol.

Authors:  D M Palac; R D Cornish; W J McDonald; D A Middaugh; D Howieson; S P Bagby
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

4.  Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease.

Authors:  Stephen R Hooper; Arlene C Gerson; Robert W Butler; Debbie S Gipson; Susan R Mendley; Marc B Lande; Shlomo Shinnar; Alicia Wentz; Matthew Matheson; Christopher Cox; Susan L Furth; Bradley A Warady
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

Review 5.  Psychomotor performance and antihypertensive treatment.

Authors:  L Kalra; C G Swift; S H Jackson
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

6.  Racial Differences in Gray Matter Integrity by Diffusion Tensor in Black and White Octogenarians.

Authors:  Ge Liu; Ben Allen; Oscar Lopez; Howard Aizenstein; Robert Boudreau; Anne Newman; Kristine Yaffe; Stephen Kritchevsky; Lenore Launer; Suzanne Satterfield; Eleanor Simonsick; Caterina Rosano
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

7.  Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy.

Authors:  Marc B Lande; Heather Adams; Bonita Falkner; Shari R Waldstein; George J Schwartz; Peter G Szilagyi; Hongyue Wang; Donna Palumbo
Journal:  J Pediatr       Date:  2010-03-15       Impact factor: 4.406

8.  The effects of mild diastolic hypertension on the results of tests of cognitive function in adults 22 to 59 years of age.

Authors:  E J Pérez-Stable; T J Coates; R Halliday; P S Gardiner; W W Hauck
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

9.  Parental assessments of internalizing and externalizing behavior and executive function in children with primary hypertension.

Authors:  Marc B Lande; Heather Adams; Bonita Falkner; Shari R Waldstein; George J Schwartz; Peter G Szilagyi; Hongyue Wang; Donna Palumbo
Journal:  J Pediatr       Date:  2008-09-27       Impact factor: 4.406

10.  Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.

Authors:  K Eliasson; T Kahan; B Hylander; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.